|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2400083264 |
|
最近更新日期: Date of Last Refreshed on: |
2024-04-19 11:44:29 |
|
注册时间: Date of Registration: |
2024-04-19 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
脑梗死阿替普酶溶栓患者住院人次及住院费用因素分析 |
|
Public title: |
Analysis of hospitalization times and hospitalization cost factors in patients with cerebral infarction treated with alteplase |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
2021年-2022年脑梗死阿替普酶溶栓患者住院人次及住院费用因素分析 |
|
Scientific title: |
Analysis of hospitalization times and hospitalization cost factors in patients with cerebral infarction treated with alteplase from 2021 to 2022 |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
王亚静 |
研究负责人: |
王亚静 |
|
Applicant: |
Wang Yajing |
Study leader: |
Wang Yajing |
|
申请注册联系人电话: Applicant telephone: |
+86 13671001100 |
研究负责人电话: Study leader's telephone: |
+86 13671001100 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
hjz0610@126.com |
研究负责人电子邮件: Study leader's E-mail: |
Hjz0610@126.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
北京市平谷区新平北路59号 |
研究负责人通讯地址: |
北京市平谷区新平北路59号 |
|
Applicant address: |
No. 59 Xinping North Road, Pinggu District, Beijing |
Study leader's address: |
No. 59 Xinping North Road, Pinggu District, Beijing |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
北京市平谷区医院 |
||
|
Applicant's institution: |
Beijing Pinggu Hospital |
||
|
研究负责人所在单位: |
北京市平谷区医院 |
||
|
Affiliation of the Leader: |
Beijing Pinggu Hospital |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2024-科015-01 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
北京市平谷区医院医学伦理委员会 |
||
|
Name of the ethic committee: |
Beijing Pinggu Hospital Medical Ethics Committee |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2024-03-13 00:00:00 |
||
|
伦理委员会联系人: |
赵翠伶 |
||
|
Contact Name of the ethic committee: |
Zhao Cuiling |
||
|
伦理委员会联系地址: |
北京市平谷区新平北路59号 |
||
|
Contact Address of the ethic committee: |
No. 59 Xinping North Road, Pinggu District, Beijing , China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 10 89978829 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
13693052773@163.com |
|
研究实施负责(组长)单位: |
北京市平谷区医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Beijing Pinggu Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
北京市平谷区新平北路59号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 59 Xinping North Road, Pinggu District, Beijing , China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
自筹 |
||||||||||||||||||||||
|
Source(s) of funding: |
Self-financing |
||||||||||||||||||||||
|
Target disease: |
Cerebral infarction |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
回顾性研究 | ||||||||||||||||||||||
|
Study phase: |
Retrospective study |
||||||||||||||||||||||
|
研究设计: |
连续入组 |
||||||||||||||||||||||
|
Study design: |
Sequential |
||||||||||||||||||||||
|
研究目的: |
分析住院费用影响因素,为本地区急性脑梗死的预防及治疗提供参考,为减轻该类患者经济负担提供依据。 |
||||||||||||||||||||||
|
Objectives of Study: |
To analyze the influencing factors of hospitalization expenses, to provide reference for the prevention and treatment of acute cerebral infarction in this area, and to provide basis for alleviating the economic burden of this kind of patients. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
2021-2022 年神经内科主诊为脑梗死且静脉给子阿替普酶溶栓治疗的患者。 |
||||||||||||||||||||||
|
Inclusion criteria |
From 2021 to 2022, the neurology department diagnosed patients with cerebral infarction who received intravenous ateplase thrombolysis treatment. |
||||||||||||||||||||||
|
排除标准: |
无 |
||||||||||||||||||||||
|
Exclusion criteria: |
None |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2024-05-01 00:00:00至 To 2024-05-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2024-05-01 00:00:00 至 To 2024-05-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
无 |
|
Blinding: |
None |
|
是否共享原始数据: IPD sharing |
No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
2024年6月,论文方式提供 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
June 2024, paper format provided |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
一病历记录表包括:1.基本信息,如性别、年龄;2.医疗信息,如主诊、其他诊断及入院病情、离院方式、住院天数等;3.费用信息:总费用。 二医院HIS和病案统计科统计系统。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
A medical record form includes: 1. Basic information, such as gender and age; 2. Medical information, such as primary diagnosis, other diagnoses and admission conditions, departure methods, length of hospital stay, etc; 3. Cost information: Total cost. Second Hospital HIS and Medical Record Statistics Department Statistical System. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
无/No |